Regulatory Science: A Legislator's Perspective
This article was originally published in RPM Report
Executive Summary
Agriculture Appropriations Subcommittee Chair Rosa DeLauro is a critical figure in FDA’s quest to secure expanded resources to support regulatory science. The good news: she believes in the cause. The bad news: she has a lot of other changes she would like to see at FDA.
You may also be interested in...
Commissioner Hamburg on R&D Productivity
The following is an excerpt from FDA Commissioner Margaret Hamburg’s keynote address to the Food & Drug Law Institute annual meeting in Washington April 4.
Sustainable Funding for Regulatory Science: FDA, Industry Hope Fourth Time is the Charm
FDA is trying one more time to secure significant resources to fund regulatory science. FDA's leadership is making good progress with key figures in the Administration and on the Hill-but the money still isn't there.
Sustainable Funding for Regulatory Science: FDA, Industry Hope Fourth Time is the Charm
FDA is trying one more time to secure significant resources to fund regulatory science. FDA's leadership is making good progress with key figures in the Administration and on the Hill-but the money still isn't there.